Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
3,150
119th Congress
Top supporter
Darline Graham
100% support rate
Top opponent
Ashley Moody
18% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in United States

Legislators moving healthcare in United States
Legislator Party Stance Support rate Decisive votes
Darline Graham
Darline Graham Senate
R
Strong +
100% 6
AA
Alan Armstrong Senate
R
Strong +
88% 8
Peter Welch
Peter Welch Senate
D
Strong +
82% 22
Ron Wyden
Ron Wyden Senate
D
Support
77% 22
Alex Padilla
Alex Padilla Senate
D
Support
76% 21
Ashley Moody
Ashley Moody Senate
R
Strong −
18% 22
Rick Scott
Rick Scott Senate
R
Strong −
18% 22
Rand Paul
Rand Paul Senate
R
Oppose
23% 22
Brad Knott
Brad Knott House · District 13
R
Oppose
28% 18
Pat Harrigan
Pat Harrigan House · District 10
R
Oppose
28% 18
Showing 751–760 of 3,150 bills

All healthcare bills

in committee · United States · House Apr 16, 2026

HR 8355: Accountable Produce is Medicine Act of 2026

The "Accountable Produce is Medicine Act of 2026" mandates the creation of a new pilot program within the Center for Medicare and Medicaid Innovation. This program requires selected healthcare providers to offer a comprehensive set of "Accountable Produce is Medicine services" to eligible Medicare, Medicaid, and CHIP beneficiaries. These services, provided without patient cost-sharing, include healthy foods (like fruits and vegetables), nutrition counseling, care coordination, and remote monitoring for individuals with specific chronic diseases in underserved areas. Participating programs will screen patients, deliver these services for a year, and track health data to evaluate outcomes and cost savings over a period of at least five years.
in committee · United States · House Apr 16, 2026

HR 8339: Drug Origin Transparency Act of 2026

This bill, titled the "Drug Origin Transparency Act of 2026," aims to increase transparency regarding the manufacturing and supply chain of drugs, primarily affecting drug manufacturers and suppliers of active pharmaceutical ingredients. It mandates that drug manufacturers submit more detailed and frequent reports to the government, identifying suppliers of active pharmaceutical ingredients and intermediate materials, including the amounts sourced from each. These reports could be required up to four times annually. Additionally, the bill requires drug labels to include the name, place of business, and unique facility identifier of the original manufacturer of both the finished drug and its active pharmaceutical ingredients. Labels must also identify all manufacturers involved, from the original active ingredient supplier to the final packer or distributor.
in committee · United States · House Apr 20, 2026

HRES 1196: Recognizing April as Cancer Prevention and Early Detection Month.

HRES 1196 is a House Resolution that formally designates April as "Cancer Prevention and Early Detection Month." The resolution expresses the House of Representatives' support for the goals and ideals of this month, affirming a national commitment to educating the public on disease prevention and commending advancements in multi-cancer early detection efforts.
Sub-Topics Public Health
in committee · United States · House Apr 14, 2026

HR 8271: ICU Bed Act of 2026

The ICU Bed Act of 2026 mandates that hospitals, critical access hospitals, and rural emergency hospitals participating in Medicare report their intensive care unit (ICU) bed availability in real time. To achieve this, these facilities must participate in shared regional data systems and develop shared strategies for efficiently transferring patients when any hospital approaches ICU capacity. The Secretary of Health and Human Services will establish these regions based on factors like geography, population, and travel time between facilities. Additionally, the bill amends the Public Health Service Act to include efficient patient transfer activities in state and regional hospital preparedness efforts, extending funding for these activities through fiscal year 2031.
in committee · United States · House Apr 22, 2026

HR 8430: Federal and State Food Safety Information Sharing Act of 2026

This bill, the Federal and State Food Safety Information Sharing Act of 2026, authorizes the Food and Drug Administration (FDA) to share unredacted food safety information with State, local, Tribal, and Territorial public health authorities. This directly affects the FDA and these various state and local entities involved in protecting public health from foodborne hazards. The shared information can include details like foodborne illness surveillance data, laboratory testing results, inspection findings, recall distribution lists, and consumer complaints, to be shared as soon as reasonably practical. While recipient authorities generally need FDA permission for further disclosure, they may do so without permission if necessary to contain an outbreak, carry out a recall, or for other state enforcement activities. Additionally, the bill extends the duration of certain federal grants for enhancing food safety from three to five years and ties subsequent grant funding to successful program evaluations.
Sub-Topics Public Health
in committee · United States · House May 21, 2026

HR 8163: Provider Reimbursement Stability Act of 2026

This bill, the Provider Reimbursement Stability Act of 2026, aims to create more predictable payment adjustments for physicians and other healthcare providers under the Medicare program. It directly affects medical practices and providers who receive reimbursement for services through the physician fee schedule. The legislation increases a threshold for certain budget neutrality calculations from $20 million to $54.3 million in 2027, with automatic increases every five years thereafter. It also requires the government to correct payment estimates when actual service usage differs significantly from projections, mandates regular updates to cost calculations for practice expenses, and limits how much Medicare payment rates can change from year to year to a maximum of 2.5 percent.
Sub-Topics Medicare
in committee · United States · House Mar 24, 2026

HR 8067: Candis King Hope for Sickle Cell Families Act

The Candis King Hope for Sickle Cell Families Act establishes a new data collection program to track the incidence, prevalence, and healthcare patterns of sickle cell disease across the United States. Funded through $10 million in annual grants from 2027 to 2031, the program directs the Centers for Disease Control and Prevention to award funding to states for gathering demographic and clinical information about sickle cell disease patients. The legislation also reinstates specific employees from the CDC's Division of Blood Disorders and Public Health Genomics who were removed in agency actions affecting 3 percent or more of the division's workforce within a 60-day period starting January 1, 2025.
Sub-Topics Public Health
in committee · United States · House Mar 20, 2026

HR 8032: FAIC Act

The FAIC Act requires Medicare to pay separately for certain high-cost cancer treatments starting in 2026, rather than bundling them into general outpatient service payments. This change applies to FDA-approved cancer drugs and biologics that do not receive special transitional payments and cost at least $350 per day. The separate payment amount will be based on the drug's average sales price or, if unavailable, its wholesale acquisition cost or mean unit cost. The law includes a budget neutrality provision to ensure total Medicare spending remains unchanged by adjusting other payments as needed.
Sub-Topics Medicare
in committee · United States · House Mar 19, 2026

HR 8011: SECURE Health Act

This bill establishes the SECURE Health Act to strengthen the global health workforce by creating a coordinated federal strategy to train, support, and protect frontline health workers worldwide. It requires the President to develop a five-year Global Health Workforce Strategy, appoint a dedicated coordinator within the State Department, and form an interagency task force to align health investments across federal agencies. The legislation mandates detailed annual reporting on funding for health worker salaries, training, and protection measures, while also calling for an independent global report every two years to track progress. Additionally, the bill emphasizes integrated funding approaches that support multiple health needs rather than single-disease programs and requires host countries to contribute to salary support plans to ensure long-term sustainability.
in committee · United States · House Apr 9, 2026

HR 8234: Save Money, Save Lives Act

The Save Money, Save Lives Act removes a budget neutrality requirement that previously limited certain Medicaid demonstration projects. This change directly affects state and local health programs that use Section 1115 waivers to test innovative healthcare delivery methods. By repealing the specific budget neutrality provision, the bill allows these programs to operate without the strict financial constraints that were previously in place. The legislation also rescinds the funding that had been set aside for enforcing this requirement.
Sub-Topics Medicaid
Showing 751 to 760 of 3,150 bills
Previous 1 … 75 76 77 … 315 Next